DR. FRANCISCO G. BADOSA, M.D.

Plain English
This study looked at two types of kidney donation surgeries: minimal incision living donor nephrectomy (MILD) and hand-assisted laparoscopic living donor nephrectomy (HAL). Researchers found that the MILD surgeries used smaller cuts than the HAL surgeries, with MILD averaging 8.6 cm compared to 11 cm and 10.4 cm for the others. Although MILD took a bit longer in the hospital post-surgery, it performed just as well in terms of safety and effectiveness, which is important because it allows more surgeons to perform this procedure safely without needing advanced tools. Who this helps: This benefits living kidney donors and the surgeons who perform their surgeries.

Plain English
This study looked at a type of kidney donation surgery called minimal incision living donor nephrectomy (MILD) and compared it with a standard open donor nephrectomy (SOD). The researchers found that MILD patients had significantly smaller incision sizes (8.6 cm versus 21.8 cm) and shorter hospital stays (average of 2.5 days compared to 4.6 days), with fewer complications overall. This matters because it shows that MILD can lead to better recovery and less discomfort for kidney donors. Who this helps: This benefits kidney donors and their surgeons.

Plain English
This study looked at how a substance called adenosine affects inflammation in transplanted rat pancreases that had been preserved in a cold solution. The researchers found that adding adenosine to the preservation solution increased certain inflammatory markers in the transplanted pancreas, while using an adenosine blocker reduced these markers, suggesting that adenosine can make inflammation worse after the transplant. This matters because understanding how adenosine influences inflammation can help improve the success of pancreas transplants. Who this helps: This helps doctors and researchers working to enhance pancreas transplant outcomes for patients.

Plain English
This study looked at how a molecule called endothelin affects inflammation during the process of pancreas transplantation, especially when blood flow is restored after a period of being blocked (called ischemia-reperfusion). The researchers found that after transplantation, levels of endothelin and inflammation markers significantly increased, which could be prevented when nitric oxide, another important molecule, was blocked. This matters because understanding these processes can help improve outcomes for patients who receive pancreas transplants by potentially reducing harmful inflammation. Who this helps: This helps patients undergoing pancreas transplantation.

Plain English
This study looked at how blocking nitric oxide affects inflammation in pancreas transplants after different lengths of preservation periods. Researchers found that when the pancreas was preserved for a short time (30 minutes), blocking nitric oxide helped reduce inflammation, but after longer preservation (12 hours), this blockage was ineffective. This matters because understanding how nitric oxide influences injury in transplanted organs can improve transplant outcomes and patient recovery. Who this helps: This helps patients undergoing pancreas transplantation.

Plain English
This study looked at how nitric oxide (NO) affects the production of a substance called endothelin during pancreas transplants. Researchers found that after a transplant, the levels of both lipase (an enzyme) and endothelin increased, particularly when the pancreas had been preserved for a short time. Understanding this connection is important because it can help improve the outcomes of pancreas transplants. Who this helps: This helps patients receiving pancreas transplants and the doctors who perform the procedures.

Plain English
This study looked at two methods for treating blocked hemodialysis grafts: balloon angioplasty and patch angioplasty. Researchers found that after one month, balloon angioplasty had a success rate of 77%, slightly lower than the 86% success rate for patch angioplasty, but at three months and six months, the rates were similar, making both methods effective. This is important because it gives doctors options for treating blocked grafts, ensuring patients can maintain their access for dialysis. Who this helps: Patients with kidney disease who require hemodialysis.

Plain English
This study looked at two methods of draining the pancreas in patients who received a pancreas and kidney transplant at the same time. Researchers found that patients using enteric drainage (ED) faced far fewer complications like dehydration and urinary infections compared to those using bladder drainage (BD). Specifically, only 3.4% of ED patients experienced volume depletion versus 34.3% of BD patients, and 26.7% of BD patients had urinary infections compared to just 0% in the ED group. This is important because it suggests that ED is a better option, leading to fewer health issues and hospital visits after transplant. Who this helps: This helps transplant patients and doctors in choosing the best method for pancreas drainage.

Plain English
This study examined a 46-year-old man who received a kidney transplant and later developed a rare tumor called an intramedullary plasmacytoma in his elbow area. After treating the tumor with four weeks of targeted radiation therapy, his pain completely went away, and he continued with a lower dose of his immunosuppressive medication. This is important because it highlights how transplant patients can develop unique complications, and effective treatment options are available. Who this helps: This helps kidney transplant patients who may face similar health challenges.

Plain English
This study looked at how two different treatments affected the production of certain molecules in rats that had undergone pancreas transplantation. The researchers found that after the transplant, levels of specific compounds increased, but administering desferrioxamine and a platelet-activating factor blocker helped reduce some of these increases, indicating that these treatments could manage harmful responses in the transplanted pancreas. This matters because it shows potential ways to improve outcomes for organ transplants by reducing damage caused during the process. Who this helps: This helps patients undergoing pancreas transplants and their doctors.

Plain English
This study looked at a surgical method called Roux-Y intestinal drainage for patients receiving a kidney and pancreas transplant at the same time. The researchers found that using this technique resulted in fewer complications compared to other methods, with no increase in major issues like graft rejection or infections. The findings are promising, as they suggest that this approach is safe and effective, leading the team to decide to use it for all future transplant patients. Who this helps: This helps patients undergoing simultaneous kidney and pancreas transplants.

Plain English
This study looked at how certain molecules in the body respond during the process of restoring blood flow to transplanted rat pancreases after they have been preserved for varying times. Researchers found that after transplantation, key compounds increased in the pancreatic tissue, regardless of how long the organs were preserved. Notably, using a particular antioxidant before re-establishing blood flow reduced these increases, indicating that oxygen damage plays a significant role in this process. Who this helps: This helps patients undergoing pancreas transplants and their doctors by improving understanding of how to protect transplanted organs.

Plain English
This study looked at patients who received pancreas and kidney transplants to see how their bodies handled insulin, especially regarding fat metabolism. Researchers found that these transplant recipients had double the insulin levels in their blood compared to healthy controls and reduced insulin receptors, meaning their bodies didn’t respond as effectively to insulin. This matters because it suggests that even after receiving a transplant, these patients can still have issues with insulin regulation and fat processing, which can lead to further health complications. Who this helps: This helps patients who have undergone pancreas and kidney transplants, as well as their doctors, by highlighting potential ongoing metabolic issues.

Plain English
The study focused on how to manage ureteral stenosis, a common complication after kidney transplants, which occurred in 24 out of 692 patients (3.4%). Researchers found that treating patients within three months after the transplant was more effective, with a success rate of 71% using a non-surgical method called percutaneous stenting, compared to just 29% success for those who developed the problem later. This matters because understanding the timing of treatment can improve outcomes for kidney transplant patients, reducing the need for surgery. Who this helps: Patients who have undergone kidney transplantation.

Plain English
This study looked at whether local radiation treatment on kidney transplants could help prevent the body from rejecting the new organ. Researchers gave 100 kidney transplant patients either regular anti-rejection medications or those medications plus radiation treatment. After two years, they found no meaningful difference in outcomes between the two groups, indicating that adding radiation does not improve transplant success. Who this helps: This information helps doctors making treatment decisions for kidney transplant patients.

Plain English
This study looked at how liver transplants affect patients' quality of life before and after the surgery. Nineteen patients completed a health questionnaire, and the results showed a significant improvement in their quality of life, especially three months after the transplant. Patients returned to work well, and on average, they only spent 12 days in the hospital each year for check-ups and procedures. Who this helps: This helps liver transplant patients and their healthcare providers.

Plain English
This study looked at how blood flow in the liver is affected when patients receive liver transplants. Researchers found that the portal contribution to blood flow was lower in patients experiencing acute rejection at 52.4%, compared to 58.8% in patients with functioning grafts, and was higher in healthy volunteers at 64.0%. This difference helps doctors diagnose liver transplant rejection more accurately, as a portal contribution above 55% suggests that rejection is unlikely. Who this helps: This helps doctors working with liver transplant patients.